Oral histoplasmosis after radiation therapy for laryngeal squamous cell carcinoma

2007 ◽  
Vol 56 (5) ◽  
pp. 871-873 ◽  
Author(s):  
Khaled Ezzedine ◽  
Isabelle Accoceberry ◽  
Denis Malvy
Cancers ◽  
2020 ◽  
Vol 12 (6) ◽  
pp. 1651 ◽  
Author(s):  
Mauricio E. Gamez ◽  
Adriana Blakaj ◽  
Wesley Zoller ◽  
Marcelo Bonomi ◽  
Dukagjin M. Blakaj

Laryngeal squamous cell carcinoma is the second most common head and neck cancer. Its pathogenesis is strongly associated with smoking. The management of this disease is challenging and mandates multidisciplinary care. Currently, accepted treatment modalities include surgery, radiation therapy, and chemotherapy—all focused on improving survival while preserving organ function. Despite changes in smoking patterns resulting in a declining incidence of laryngeal cancer, the overall outcomes for this disease have not improved in the recent past, likely due to changes in treatment patterns and treatment-related toxicities. Here, we review emerging concepts and novel strategies in the use of radiation therapy in the management of laryngeal squamous cell carcinoma that could improve the relationship between tumor control and normal tissue damage (therapeutic ratio).


2015 ◽  
Vol 22 (3) ◽  
pp. 704-713 ◽  
Author(s):  
Maria Vassilakopoulou ◽  
Margaritis Avgeris ◽  
Vamsidhar Velcheti ◽  
Vassiliki Kotoula ◽  
Theodore Rampias ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document